Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure-Reference-Cited by-同舟云学术

Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure

Published:2020-06-01 Issue:6 Volume:5 Page:643
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Fudim Marat¹²,Ali-Ahmed Fatima²³,Parzynski Craig S.⁴,Ambrosy Andrew P.⁵⁶,Friedman Daniel J.¹²,Pokorney Sean D.¹²,Curtis Jeptha P.⁴,Fonarow Gregg C.⁷⁸⁹,Masoudi Frederick A.¹⁰,Hernandez Adrian F.¹²¹¹,Al-Khatib Sana M.¹²

Affiliation:

1. Division of Cardiology, Duke University Medical Center, Durham, North Carolina

2. Duke Clinical Research Institute, Durham, North Carolina

3. Beaumont Health, Dearborn, Michigan

4. Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut

5. Department of Cardiology, The Permanente Medical Group, San Francisco, California.

6. Division of Research, Kaiser Permanente Northern California, Oakland, California

7. Division of Cardiology, David Geffen School of Medicine at UCLA (University of California, Los Angeles)

8. Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, University of California, Los Angeles

9. Section Editor, JAMA Cardiology

10. Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora

11. Associate Editor, JAMA Cardiology

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2763017/jamacardiology_fudim_2020_oi_200012.pdf

Reference16 articles.

1. Who has advanced heart failure?: definition and epidemiology.;Abouezzeddine;Congest Heart Fail,2011

2. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.;Al-Khatib;Heart Rhythm,2018

3. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.;Lindenfeld;Circulation,2007

4. Review of the ICD Registry’s third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance.;Hammill;Heart Rhythm,2009

5. The National Cardiovascular Data Registry (NCDR) data quality brief: the NCDR Data Quality Program in 2012.;Messenger;J Am Coll Cardiol,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient‐Level Meta‐Analysis;Journal of the American Heart Association;2024-08-06

2. Axitinib targets cardiac fibrosis in pressure overload-induced heart failure through VEGFA-KDR pathway;Frontiers in Medicine;2023-11-10

3. Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis;2023-07-06

4. Optimizing exercise testing‐based risk stratification to predict poor prognosis after acute heart failure;ESC Heart Failure;2022-12-02

5. A Holistic View of Advanced Heart Failure;Life;2022-08-24